A Phase I/II, Open-Label, Multiple Centre Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of LM-302 in Combination with Toripalimab in Patients with Advanced Solid Tumors

  • Frentzas, Sophia (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date5/04/22 → 31/01/27

Keywords

  • pharmacokinetics
  • Phase 1 and 2 study
  • treatment efficacy
  • treatment safety
  • immunogenetics
  • solid tumour

Clinical Trial Phase

  • Phase I
  • Phase II